PHMB PharmaCom BioVet Inc (CE)

PharmaCom BioVet, Inc. (PINKSHEETS: PHMB) is pleased to announce a well-respected research firm, Market Advisors, Inc., has initiated coverage on PHMB. The research report highlights the overall operations and business plan unfolding for the firm. Market Advisors has been reporting on publicly trading companies since the early 1980s and has identified PHMB as a company worth noting.

In the report, it states that these are exciting and challenging opportunities in the areas of bone marrow transplant and other cancer treatment technologies for companion animals. The company appears to be well positioned to use its capital and management skills to evaluate new ventures, as well as implement plans for current ventures, and to operate its new centers to achieve sales and revenue growth.

To view the entire independent research report visit the following link: http://pharmacombiovet.blogspot.com

PharmaCom BioVet, Inc. is quickly positioning itself to becoming the leader in specialized veterinary oncology (cancer treatment facilities for animals). PHMB management is planning the rollout of specialized Veterinary Oncology Treatment Centers that will be strategically located throughout the United States. PHMB has licensed a series of proprietary devices and compounds that will enable animals suffering from cancer a potentially greater life expectancy and decreased suffering.

Disclaimer:

PHMB has no relationship with Market Advisors nor advised or suggested to Market Advisors any of the contents of its reports, and takes no responsibility for the accuracy of the statements therein.

The information and opinions in this analyst report were prepared by Market Advisors, Inc. (located in Nebraska) who does receive fees for services including preparation of this report. For this report, officers of Market Advisors, Inc received $2,700 from, a third party, for this research report.

Forward-Looking Statements:

This press release contains forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially.

Contact: Investor Relations Tel: (919) 701-4574 URL: http://www.PharmaComBioVet.com